When our group reported last year that mutations in GDF2 were found in three patients with a telangiectasia syndrome, a decision was made to stop short of labeling it a new type of HHT, because it was not clear that the dermal telangiectases were typical of HHT as described in the Curaçao criteria. This evidence concerns the gene GDF2 and Telangiectasia.